 |
|
 Identifying patients who can most benefit from weight loss is an appropriate strategy in managing their health. These include patients who already have an obesity-related comorbidity and a body mass index (BMI) of 27 or more, or patients with a BMI of 30 or more with or without comorbidities. You may find the following tools helpful in assessing and diagnosing your patients' conditions and levels of risk. You may also need to evaluate your patients' behavior and attitudes to determine whether XENICAL is right for them. BMI: Your Primary Diagnostic Tool Inexpensive and accessible in the clinical setting, BMI is emerging as an important and widespread clinical marker for determining health risk. Risks for type 2 diabetes, hypertension and hypercholesterolemia are substantially greater for individuals with a BMI of 27 or more. Use BMI as a tool to assist in identifying patients with obesity-level BMI values. Moderators of Health Risks In addition to BMI, fat distribution is a significant indicator for determining health risks. Evaluating Patient Behavior and Motivation Is the patient committed to changing his or her lifestyle? Here are several forms that can help you assess your patients' weight-loss history, current lifestyle, and attitudes to increase the likelihood of success. Diagnostic Codes for Treating Obesity-Related Comorbidities Refer to this quick reference when treating obesity-related comorbidities. Remember that your local Genentech representative has numerous tools and teaching aids to assist you in diagnosing, educating, and treating patients. | |||||||
|
|
||||||||
|
|
|
|||||||
|
|
|
|
|
|
||||
|
|
|
|
||||||
